Viewing Study NCT05506605


Ignite Creation Date: 2025-12-25 @ 3:29 AM
Ignite Modification Date: 2026-05-29 @ 12:25 PM
Study NCT ID: NCT05506605
Status: UNKNOWN
Last Update Posted: 2023-09-21
First Post: 2022-07-22
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Switch Strategy From Etravirine (ETR) to Doravirine (DOR) in Virologically-Suppressed HIV-1 Infected Adults With ETR-Resistance
Sponsor: Fundacion Clinic per a la Recerca Biomédica
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None HIV-1-infection View
Keywords:

Keywords

Keyword Brief Keyword Text View
None HIV View
None Doravirine View
None Etravirine View